Abstract
In order to test the hypothesis that a 5-hydroxytryptamine (5-HT)-induced increase in vascular permeability results from a cascade triggered by activation of the synthesis of nitric oxide (NO), the vascular permeability was investigated using the Pontamine sky blue leakage method in male mice. Subcutaneous injection of 5-HT induced a dose-related increase of vascular permeability at the injection site. The vascular permeability induced by 5-HT was inhibited by pretreatment with intraperitoneal injection of ketanserin (5-HT2A antagonist) and methysergide (5-HT1/2A antagonist), less efficiently by 1-(2-methoxyphenyl)-4-[4-(2-phthalimido)butyl] piperazine (NAN-190) (5-HT1A antagonist), but not by granisetron (5-HT3 antagonist). Increase in vascular permeability induced by 5-HT was inhibited by concurrent intravenous administration of NO synthase inhibitors NG-nitro-Lrarginine methyl ester (L-NAME) and methylene blue but not by the inactive enantiomer NG-nitro-D-arginine methyl ester (D-NAME). These results suggest that 5-HT increases vascular permeability by activating the 5-HT receptors and that endogenous NO is involved in this effect of 5-HT.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Arvier PT, Chahl LA, Ladd RJ (1977) Modification by capsaicin and compound \4880 of dye leakage induced by irritants in the rat. Br J Pharmacol 59:61–68
Bodelsson M, Arneklo-Nobin B, Törnebrandt K (1989) Cooling augments contractile response to 5-hydroxytryptamine via an endothelium-dependent mechanism. Blood Vessels 26:347–359
Cocks TM, Angus JA (1983) Endothelium-dependent relaxation of coronary arteries by noradrenaline and serotonin. Nature 305:627–630
Cohen RA, Shepherd JT, Vanhoutte PM (1983) 5-Hydroxytryptamine can mediate endothelium-dependent relaxation of coronary arteries. Am J Physiol 245:H1077–H1080
De Clerck F, Van Gorp L, Beetens J, Reneman RS (1985) Platelet-mediated vascular permeability in the rat: a predominant role for 5-hydroxytryptamine. Thromb Res 38:321–339
Fujii E, Irie K, Muraki T (1994) Nitric oxide plays a role in increase in vascular permeability induced by bradykinin but not by platelet-activating factor (PAF) or histamine in mouse skin. Jpn J Pharmacol [Suppl I]64:312p
Furchgott RF (1984) The role of endothelium in the responses of vascular smooth muscle to drugs. Ann Rev Pharmacol Toxicol 24:175–197
Glennon RA, Naiman NA, Pierson ME, Titeler M, Lyon RA, Weisberg E (1988) NAN-190: an arylpiperazine analog that antagonizes the stimulus effects of the 5-HT1A agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT). Eur J Pharmacol 154:339–341
Hughes SR, Williams TJ, Brain SD (1990) Evidence that endogenous nitric oxide modulates oedema formation induced by substance P. Eur J Pharmacol 191:481–484
Humphrey PPA, Hartig P, Hoyer D (1993) A proposed new nomenclature for 5-HT receptors. TIPS 14:233–236
Iadecola C, Zhang F, Xu X (1993) Role of nitric oxide synthase-containing vascular nerves in cerebrovasodilation elicited from cerebellum. Am J Physiol 264:R738-R746
Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G (1987) Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 84:9265–9269
Leme JG, Hamamura L, Migliorini RH, Leite MP (1973) Influence of diabetes upon the inflammatory response of the rat. A pharmacological analysis. Eur J Pharmacol 23:74–81
Lipton SA, Choi Y-B, Pan Z-H, Lei SZ, Chen H-SV, Sucher NJ, Loscalzo J, Singel DJ, Stamler JS (1993) A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 364:626–632
Lüscher TF, Vanhoutte PM (1986) Endothelium-dependent responses to platelets and serotonin in spontaneously hypertensive rat. Hypertension 8 [Suppl 2]:55–60
Maling HM, Webster ME, Williams MA, Saul W, Anderson W Jr (1974) Inflammation induced by histamine, serotonin, bradykinin and compound \4880 in the rat: antagonists and mechanisms of action. J Pharmacol Exp Ther 191:300–310
Marczin N, Ryan US, Catravas JD (1992) Methylene blue inhibits nitrovasodilator- and endothelium-derived relaxing factor-induced cyclic GMP accumulation in cultured pulmonary arterial smooth muscle cells via generation of superoxide anion. J Pharmacol Exp Ther 263:170–179
Mayer B, Brunner F, Schmidt K (1993) Inhibition of nitric oxide synthesis by methylene blue. Biochem Pharmacol 45:367–374
Moncada S, Vane JR (1979) Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2 and prostacyclin. Pharmacol Rev 30:293–331
Moncada S, Herman AG, Vanhoutte PM (1987) Endothelium-derived relaxing factor is identified as nitric oxide. TiPS 8:365–367
Oyanagui Y, Sato S (1993) Histamine paw edema of mice was increased and became H2-antagonist sensitive by co-injection of nitric oxide forming agents, but serotonin paw edema was decreased. Life Sci 52:159–164
Palmer RMJ, Ferrige AG, Moncada S (1987) Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327:524–526
Rees DD, Palmer RMJ, Moncada S (1989) Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci 86:3375–3378
Yuan Y, Granger HJ, Zawieja DC, DeFily DV, Chilian WM (1993) Histamine increases venular permeability via a phospholipase C-NO synthase-guanylate cyclase cascade. Am J Physiol 264 (Heart Circ Physiol 33):H1734–1739
Author information
Authors and Affiliations
Additional information
Correspondence to: E. Fujii at the above address
Rights and permissions
About this article
Cite this article
Fujii, E., Irie, K., Uchida, Y. et al. Possible role of nitric oxide in 5-hydroxytryptamine-induced increase in vascular permeability in mouse skin. Naunyn-Schmiedeberg's Arch Pharmacol 350, 361–364 (1994). https://doi.org/10.1007/BF00178952
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00178952